Search clinical trials for: BR3006-3

Total 7424 results

Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers

Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

Rheumatoid Arthritis

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.

Diabetes Mellitus, Type 2

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Type2 Diabetes Mellitus

Korea, Republic of
BrodenBio Co., Ltd.

Recruiting

A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers

Dementia Alzheimers

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Gastric or Duodenal Ulcer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers

Hepatocellular Carcinoma

Korea, Republic of
CStone Pharmaceuticals

Completed

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

China
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
Shanghai Best-Link Bioscience, LLC

Recruiting

A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours

Advanced Solid Tumor

China
Zhejiang Doer Biologics Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor

China
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

Gastric or Duodenal Ulcers

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers

Gastric or Duodenal Ulcer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
CStone Pharmaceuticals

Completed

A Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Solid Tumor, Adult

Australia
Boryung Pharmaceutical Co., Ltd

Completed

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Cochlear Bone Anchored Solutions

Completed

Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System

Conductive Hearing Loss

Netherlands, Sweden, United Kingdom
University of Washington
Janssen Research & Development, LLC

Terminated

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Double-Negative Prostate Carcinoma

United States
Dragonboat Biopharmaceutical Company Limited
West China Hospital

Recruiting

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

Advanced Solid Tumors (Including GCTTS)

China
Aarhus University Hospital
Denmark: Danaflex A/S, national distributor of Cochlear Ltd

Completed

Comparative Study of Two Surgical Techniques for Soft Tissue Healing and Implant Stability of Cochlear BI300 Implants.

Hearing Loss, Conductive

Denmark
Binhui Biopharmaceutical Co., Ltd.

Recruiting

oHSV2-PD-L1/CD3-BsAb Administered Via Intramural Injection

Solid Tumor

United States
Cochlear Bone Anchored Solutions

Completed

Clinical and Health Economic Evaluation With a New Baha® Abutment Combined With a Minimally Invasive Surgical Technique

Hearing Loss | Deafness | Hearing Loss, Conductive | Hearing Loss, Mixed Conductive-Sensorineural

Netherlands, France, Spain, Sweden
Spark Therapeutics

Active, not recruiting

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

Lysosomal Storage Diseases | Glycogen Storage Disease Type II | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase Deficiency

United States, Canada, Netherlands, France, Denmark, Germany, Italy, United Kingdom
Precigen, Inc

Recruiting

PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Eastern Mediterranean University

Completed

Effect Of Meal Frequency On Weight Loss And Body Composition Of Obese And Overweight Women

Overweight and Obesity

Cyprus
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Prostate Cancer

Korea, Republic of
Edwards Lifesciences

Active, not recruiting

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR)

Heart Diseases | Aortic Stenosis, Severe

United States, Canada
Aarhus University Hospital

Completed

Stability of the Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery

Hearing Loss - Conductive

Denmark
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial

Chronic Hepatitis B

China
Edwards Lifesciences

Recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR (PROGRESS)

Aortic Valve Stenosis | Aortic Stenosis, Calcific

United States, Switzerland, Australia, Japan, Canada, Netherlands
University of Aarhus
Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark; Department...

Completed

Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes (PreKetone)

Ketosis | Postprandial Hyperglycemia | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Denmark
Edwards Lifesciences

Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Pulmonary Valve Insufficiency | Complex Congenital Heart Defect | Dysfunctional RVOT Conduit | Pulmonary Valve Degeneration

United States
Assiut University

Completed

Galectin-3 and Placenta Accreta

Placenta Accreta

Egypt
Vibeke Moen

Completed

Do Changes in Plasma Osmolality Influence Ventilation? (OSM)

Hypernatraemia | Hyponatraemia

Sweden
University of Massachusetts, Worcester

Withdrawn

Asthma Exacerbation and Helium-3 MRI

Asthma Exacerbation

United States
Sheffield Children's NHS Foundation Trust
University of Sheffield

Completed

The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis (SABRE)

Acute Bronchiolitis

United Kingdom
UNICANCER

Completed

Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy

Breast Cancer

France
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Terminated

Safety of VSL#3 in Adult Asthmatics

Asthma

United States
LifeScan Scotland Ltd
Institute for Diabetes-Technology GmbH

Completed

Project Frazier 3 Regulatory Clinical Evaluation

Diabetes Mellitus | Healthy Volunteers

United Kingdom, Germany
Raphaelle Jaquet-Pilloud
Swiss Foundation for the Health of Children and Adolescents

Completed

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

Moderate to Severe Bronchiolitis

Switzerland
Children's Hospital Los Angeles
Thrasher Research Fund; UCSF Benioff Children's Hospital Oakland

Completed

Nebulized Hypertonic Saline for Bronchiolitis

Bronchiolitis

United States
Jeffrey A. Cohen, MD
Jacobus Pharmaceutical

Terminated

Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) (3-4DAP)

Muscle Weakness

United States
Dayton Children's Hospital
National Institutes of Health (NIH)

Terminated

The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3)

Irritable Bowel Syndrome

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Breast Neoplasms | Arthralgia

United States
Edwards Lifesciences

Recruiting

PARTNER 3 Trial - Aortic Valve-in-Valve

Aortic Stenosis | Aortic Stenosis, Severe

United States, Canada

Search clinical trials for: BR3006-3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations